在过器上消化蛋白质学揭示了药物点,并定位了连接物结合部位
Bohdana Sokolova1, Hassan Gharibi1,2,3, Maryam Jafari1,4
1Division of Physiological Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-17 177 Stockholm, Sweden.
Journal of proteome research
|February 7, 2026
概括
过上消化蛋白质组学 (AFDIP) 是一种新方法,用于监测蛋白质消化的速度,以确定药物标. 这种技术克服了现有方法的局限性,为药物发现提供了更简单的样本准备和更深入的蛋白质组分析.
科学领域:
- 化学蛋白质组学 化学蛋白质组学
- 分子动力学分子动力学
- 结构生物学是结构生物学.
背景情况:
- 鉴定药物与蛋白质相互作用对于了解药物的疗效和毒性至关重要.
- 现有的化学蛋白质组学方法具有局限性和局限性.
- 有一个盲点,一个盲点.
- 需要补充技术.
研究的目的:
- 介绍上过消化蛋白学 (AFDIP) 作为一种新的方法来识别药物蛋白相互作用.
- 解决当前化学蛋白质学方法的局限性.
- 提供对药物结合部位的结构性见解.
主要方法:
- 监测试素的消化速率,这些消化速率在带结合部位下降.
- 使用分子动力学模拟来将消化变化与骨干灵活性相关联.
- 用药物度作为变量进行二维分析.
主要成果:
- AFDIP通过检测改变的素消化,确定了药物和代谢物标.
- 该方法确定了结合点,结晶学位置的距离≤10 Å,对于较大的蛋白质,分辨率提高 (≤5 Å).
- 与现有方法相比,证明了更简单的样本准备,更深层次的蛋白质覆盖和更广泛的序列分析.
结论:
- AFDIP有效地识别药物点和结合部位,补充现有的化学蛋白质组学工具.
- 该方法在样本准备,蛋白质组深度和序列覆盖方面具有优势.
- 通过解决盲点和提供结构性见解,AFDIP增强了化学蛋白质组学工具包.
相关概念视频
Ligand Binding Sites
15.1K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.1K
Ligand Binding Sites
8.8K
8.8K
Ligand Binding and Linkage
5.6K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.6K
Ligand Binding and Linkage
4.1K
4.1K
Tissue-Drug Binding: Localization of Drugs and its Significance
447
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
447
The Equilibrium Binding Constant and Binding Strength
15.1K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.1K


